statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	663
RU - Federazione Russa	315
CN - Cina	171
SG - Singapore	168
IT - Italia	96
VN - Vietnam	74
BR - Brasile	60
GB - Regno Unito	55
SE - Svezia	44
IE - Irlanda	39
DE - Germania	38
FR - Francia	33
HK - Hong Kong	30
IN - India	25
KR - Corea	21
FI - Finlandia	14
CA - Canada	11
ID - Indonesia	10
UA - Ucraina	10
JP - Giappone	9
PK - Pakistan	8
PL - Polonia	7
TW - Taiwan	7
BE - Belgio	6
AR - Argentina	5
ES - Italia	5
IQ - Iraq	5
AT - Austria	4
AU - Australia	4
CO - Colombia	4
NG - Nigeria	4
NL - Olanda	4
SA - Arabia Saudita	4
IR - Iran	3
JO - Giordania	3
MA - Marocco	3
PH - Filippine	3
ZA - Sudafrica	3
BO - Bolivia	2
DZ - Algeria	2
EC - Ecuador	2
EG - Egitto	2
GR - Grecia	2
JM - Giamaica	2
KG - Kirghizistan	2
ML - Mali	2
MX - Messico	2
TR - Turchia	2
AE - Emirati Arabi Uniti	1
BD - Bangladesh	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
ET - Etiopia	1
HR - Croazia	1
LV - Lettonia	1
MY - Malesia	1
NC - Nuova Caledonia	1
NP - Nepal	1
OM - Oman	1
PS - Palestinian Territory	1
PY - Paraguay	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
UG - Uganda	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.007

Nome	#
Onconase cytotoxicity in melanoma cancer cells: promising results to be enforced by oligomerizing the protein	245
Antitumor effect of Onconase in A375 melanoma cell line. A proteomic analysis.	214
Investigations on onconase dimerization.	179
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells	169
Human angiogenin dimerization and S28N pathogenic mutation.	166
Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability	158
Dimerization of human angiogenin and of variants involved in neurodegenerative diseases	158
RNase A domain-swapped dimers produced through different methods: structure–catalytic properties and antitumor activity	156
Properties of RNase A monomer and dimers depend on the oligomerization pathway followed.	154
Influence of onconase in the therapeutic potential of PARP inhibitors in A375 malignant melanoma cells	150
STRUCTURAL DETERMINANTS AFFECTING THE OLIGOMERIZATION TENDENCY OF SOME PANCREATIC RIBONUCLEASES	143
NMR characterization of angiogenin variants and tRNAAla products impacting aberrant protein oligomerization	138
Totale	2.030

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	54	0	0	0	0	0	0	0	0	0	10	10	34
2021/2022	101	15	31	7	0	3	4	1	4	4	1	8	23
2022/2023	262	12	35	20	48	20	64	1	20	28	0	5	9
2023/2024	136	8	8	4	15	10	20	3	26	0	8	25	9
2024/2025	323	26	18	8	62	21	5	22	16	40	22	28	55
2025/2026	880	60	48	53	154	250	61	76	45	67	66	0	0
Totale													2.030

CATALOGO DEI PRODOTTI DELLA RICERCA